Market Movers (8-K)
See all →NASDAQ
Aehr Test Systems announced record quarterly bookings and a $100 million effective backlog, projecting fiscal 2027 revenue between $130 million and $150 million.
Better than expected
NASDAQ
Aehr Test Systems has successfully completed its at-the-market equity offering program, raising $60 million in gross proceeds.
Capital raise
NASDAQ
AEHR Test Systems has entered into an equity distribution agreement to offer and sell up to $60 million of its common stock through William Blair & Company, L.L.C. and Craig-Hallum Capital Group LLC.
Capital raise
NASDAQ
Aehr Test Systems reported strong Q3 FY26 bookings of $37.2 million, driven by AI and data center demand, despite a dip in net revenue to $10.3 million.
Worse than expected
NASDAQ
Aehr Test Systems reported softer Q2 FY26 revenue but reinstated fiscal 2026 guidance, citing improved visibility from AI processor and data center semiconductor test and burn-in systems.
Worse than expected
Capital raise
NASDAQ
Aehr Test Systems stockholders approved amendments to the 2006 Employee Stock Purchase Plan and the 2023 Equity Incentive Plan, increasing share limits for employee and equity awards.
Quarterly Earnings (10-Q)
See all →NASDAQ
Aehr Test Systems announced its third-quarter fiscal year 2026 results, reporting a significant decrease in revenue driven by lower shipments of wafer-level products, partially offset by growth in package-level burn-in systems.
Worse than expected
Capital raise
NASDAQ
Aehr Test Systems reported a significant net loss and revenue decline for the second quarter and first half of fiscal 2026, primarily due to softness in electric vehicle demand, despite strong growth in AI-related system sales.
Worse than expected
Capital raise
NASDAQ
Aehr Test Systems reported a significant net loss and revenue decline in its first fiscal quarter, primarily due to reduced demand in the electric vehicle sector, despite growth in AI and electrification markets.
Delay expected
Worse than expected
Capital raise
NASDAQ
10-Q: Aehr Test Systems Reports Q3 2025 Results: Revenue Jumps but Profitability Dips Amidst Market Shifts
Aehr Test Systems' Q3 2025 revenue increased significantly year-over-year, driven by system and contactor shipments, but profitability was impacted by acquisition-related costs and market softness.
Worse than expected
Capital raise
NASDAQ
10-Q: Aehr Test Systems Reports Q2 2025 Results: Revenue Declines Amid Soft Power Semiconductor Demand
Aehr Test Systems' Q2 2025 revenue decreased due to lower system shipments and service delivery, impacted by softened power semiconductor demand for electric vehicles.
Worse than expected
Capital raise
NASDAQ
Aehr Test Systems' first quarter revenue for fiscal year 2025 decreased to $13.1 million, down from $20.6 million in the same period last year, primarily due to a decline in system shipments driven by reduced demand in the electric vehicle market.
Worse than expected
Annual Reports (10-K)
NASDAQ
Aehr Test Systems announces fiscal year 2026 results, showing a revenue decrease driven by softness in electric vehicle power semiconductors, partially offset by growth in silicon photonics.
Capital raise
Worse than expected
NASDAQ
10-K: Aehr Test Systems Reports Fiscal 2025 Net Loss Amidst EV Market Softness and Strategic Shift to AI
Aehr Test Systems experienced a significant revenue decline and net loss in fiscal year 2025, primarily due to reduced demand in the electric vehicle power semiconductor market, while strategically expanding into the artificial intelligence sector through the acquisition of Incal Technology.
Worse than expected
Capital raise
Delay expected
NASDAQ
Aehr Test Systems' annual report reveals a slight revenue increase and a significant tax benefit due to the release of a valuation allowance, amidst a competitive semiconductor equipment market.
Better than expected
Delay expected
Insider Trading (Form 4)
See all →NASDAQ
Adil Engineer, Chief Operating Officer of Aehr Test Systems, reported a transaction in 500 shares of common stock on August 14, 2026.
NASDAQ
Howard T Slayen, a Director of Aehr Test Systems, sold 5,700 shares of common stock on August 14, 2026 for $133.03 per share.
NASDAQ
Rhea J Posedel, a Director of Aehr Test Systems, sold 5,973 shares of common stock on August 14, 2026 for $140.00 per share.
NASDAQ
Gayn Erickson, President and CEO and a Director of Aehr Test Systems, sold 40,000 shares of common stock on August 12, 2026.
NASDAQ
Rhea J Posedel, a Director of Aehr Test Systems, sold 8,413 shares of common stock on August 12, 2026 for $130.00 per share.
NASDAQ
Geoffrey Gates Scott, a Director of Aehr Test Systems, sold 20,000 shares of common stock on August 12, 2026 for $131.51 per share.
Proxy Statements (Def-14A)
NASDAQ
Aehr Test Systems will hold its Annual Meeting on October 20, 2025, seeking shareholder approval for increased share reserves for its equity incentive and employee stock purchase plans, director elections, and executive compensation matters.
Worse than expected
NASDAQ
Aehr Test Systems sets date for its annual shareholder meeting on October 21, 2024, to elect directors, ratify the selection of its accounting firm, and approve executive compensation.
Schedule 13G - Passive Investments
See all →NASDAQ
AWM Investment Company, Inc. has filed a Schedule 13G, disclosing a 1.1% beneficial ownership of AEHR Test Systems' common stock as of June 30, 2026.
NASDAQ
Jane Street Group, LLC and its affiliates have reported a beneficial ownership stake of 5.1% in AEHR Test Systems.
NASDAQ
FMR LLC and Abigail P. Johnson have reported beneficial ownership of 7.0% of AEHR TEST SYSTEMS' common stock as of March 31, 2026.
NASDAQ
The Vanguard Group reports zero beneficial ownership in Aehr Test Systems following an internal corporate realignment for disaggregated reporting.
NASDAQ
Baillie Gifford & Co, a UK-based investment adviser, has disclosed a 4.3% beneficial ownership stake in AEHR TEST SYSTEMS as of December 31, 2025.
NASDAQ
Baillie Gifford & Co, a UK-based investment adviser, has reported a 5.1% beneficial ownership stake in AEHR TEST SYSTEMS common stock.